SCHEMBL1983277

SCHEMBL1983277

O=S(=O)(Cc1ccccc1)N1CCC(c2ccccc2)CC1

nearest known ligand 0.68

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.63
TSHR P16473 1/20 0.63
ALDH1A1 P00352 2/20 0.58
MAPT P10636 2/20 0.58
NPSR1 Q6W5P4 2/20 0.58
HSD17B10 Q99714 1/20 0.58
POLB P06746 1/20 0.56
PKM P14618 1/20 0.56
KMT2A Q03164 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5541280 0.90 HPGD (0.55) HPGDTSHRALDH1A1MAPTNPSR1
SCHEMBL735675 0.82 TSHR (0.81) HPGDTSHRALDH1A1POLBKMT2A
SCHEMBL28949192 0.82 HPGD (0.68) HPGDTSHRALDH1A1MAPTNPSR1
SCHEMBL7239112 0.82 HPGD (0.65) HPGDTSHRALDH1A1MAPTNPSR1
SCHEMBL12424630 0.82 POLB (0.74) HPGDTSHRALDH1A1MAPTNPSR1
SCHEMBL27857138 0.79 NPSR1 (0.72) HPGDTSHRALDH1A1MAPTNPSR1
SCHEMBL15014074 0.79 NPSR1 (0.64) HPGDTSHRALDH1A1MAPTNPSR1
SCHEMBL8222746 0.79 HPGD (0.61) HPGDTSHRALDH1A1MAPTNPSR1
SCHEMBL4009474 0.79 HPGD (0.61) HPGDTSHRALDH1A1MAPTNPSR1
SCHEMBL6738518 0.79 TSHR (0.96) HPGDTSHRALDH1A1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2509945-A1 4- (AZACYCLOALKYL) -BENZENE-1, 3 -DIOL DERIVATIVES AS TYROSINASE INHIBITORS AND THEIR SYNTHESIS AND USE THEREOF Galderma Research & Development (FR) 2012-10-17 EP disclosed
WO-2011070080-A1 4- (AZACYCLOALKYL) -BENZENE-1, 3 -DIOL DERIVATIVES AS TYROSINASE INHIBITORS AND THEIR SYNTHESIS AND USE THEREOF GALDERMA RESEARCH & DEVELOPMENT (FR) 2011-06-16 WO disclosed